Navigation Links
Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
Date:4/15/2008

overexpress the protein ErbB2, or

Her2, with PCI-24781 led to control of tumors in 80 percent of the

animals, with most achieving partial response.

-- Pharmacyclics researchers also presented a study identifying biomarkers

that may be useful in predicting the tumor sensitivity to treatment

with PCI-24781.

"These studies demonstrate that PCI-24781 may have a role in the treatment of cancers associated with overexpression of ErbB2 or HER2," said Joseph J. Buggy, Ph.D., vice president of research for Pharmacyclics. "We look forward to results from our ongoing Phase 1 study of this promising compound."

An additional study was presented on Pharmacyclics' PCI-34051, a novel, selective inhibitor of HDAC-8, a protein involved in T-cell leukemia that is also critical in immune function. In previous studies, PCI-34051 was shown to exhibit a greater than 200-fold selectivity to HDAC-8 compared with other HDAC enzymes. The compound selectively induced apoptosis, or cell death, in human T-cell lymphomas and leukemias in vitro. PCI-34051 exhibits anti-inflammatory properties, such as blocking secretion of cytokines from activated monocytes and other inflammatory cells, and has been shown to prevent hypersensitivity in animal models.

"We believe that PCI-34051 is a truly selective HDAC-8 inhibitor," said Sriram Balasubramanian, Ph.D., director of translational research for Pharmacyclics. "This study further demonstrates that blocking HDAC-8 has anti- inflammatory effects that may be useful for treatment of certain lymphomas and immune-mediated diseases."

About HDAC Inhibitors

Histone deacetylases are a family of related enzymes important in managing a multitude of cellular functions. HDAC inhibitors are a new class of drugs that modulate transcriptional activity in cells and may block angiogenesis and cell cycling, key components of tumor proliferation. HDAC inhibitors also appear to promote apoptosis (ce
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
2. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
3. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
4. NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection
5. Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
6. MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics
7. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
8. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
9. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
10. New Study Reports That Physical Therapy Treatment Resolves Symptoms of Urinary Incontinence in Women
11. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 Aileron Therapeutics, ... Summary Global Markets Direct,s, ,Aileron Therapeutics, Inc. ... overview of the Aileron Therapeutics, Inc.,s pharmaceutical research ... information on the current therapeutic developmental pipeline of ... various stages, therapeutics assessment by drug target, mechanism ...
(Date:9/30/2014)... DENVER , Sept. 30, 2014  According ... "the world of cancer clinical trials is going ... clinical trials and the work of the current ... these types of ,next generation, clinical trials, which ... tomorrow."  The company has been ...
(Date:9/30/2014)... 2014   Easy Breathe , the fastest growing ... that it now offers the revolutionary AirSense ... first sleep apnea therapy devices with internal cellular modems.  ... track and share real-time data on each user,s quality ... therapy.  In addition, the internal modem allows the CPAP ...
Breaking Medicine Technology:Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 4
... BEDFORD, Mass., Feb. 4, 2011 Hologic, Inc. ... ), a leading developer, manufacturer and supplier of ... products dedicated to serving the healthcare needs of ... Administration (FDA) has approved Hologic,s pharmaceutical named Makena™ ...
... SPRING, Md., Feb. 4, 2011 The U.S. Food ... to reduce the risk of preterm delivery before 37 ... of at least one spontaneous preterm birth.   ... is not intended for use in women with a ...
Cached Medicine Technology:FDA Approves Hologic's Makena™ (Formerly Referred to as Gestiva™) Pharmaceutical 2FDA Approves Drug to Reduce Risk of Preterm Birth in At-Risk Pregnant Women 2FDA Approves Drug to Reduce Risk of Preterm Birth in At-Risk Pregnant Women 3
(Date:10/1/2014)... 2014 The Oliver Law Group ... Other-Sonic Ultrasound Gel lawsuit web page ... litigation surrounding the 2011 Pseudomonas aeruginosa / bacterial ... Oak, Michigan, which was ultimately traced to the ... William Beaumont patients who allegedly became ill following ...
(Date:10/1/2014)... The annual Social Security cost-of-living adjustment (COLA) ... a new forecast by The Senior Citizens League (TSCL) ... (CPI) data through August, TSCL forecasts that COLAs will be ... consecutive year of record low COLAs,” states TSCL Chairman, Ed ... in 1975,” he notes. , Over the past five years ...
(Date:9/30/2014)... same time could stop them from becoming resistant to ... Research * today (Wednesday). , The researchers, ... MedImmune, the global biologics research and development arm of ... two treatments helped the immune system hunt down and ... radiotherapy in mice with breast, skin and bowel cancers. ...
(Date:9/30/2014)... HealthDay Reporter TUESDAY, Sept. 30, 2014 ... surfaced in the United States, involving a man who recently ... The critically ill patient, being cared for at Texas ... the deadly virus, officials from the U.S. Centers for Disease ... The man is receiving intensive care in isolation at ...
(Date:9/30/2014)... for doctors to measure damaging "brain tsunamis" in ... a step closer to reality, thanks to pioneering ... Institute. , The research team, led by Jed ... of neurosurgery at the UC College of Medicine, ... through an injured brain like tsunami wavescan be ...
Breaking Medicine News(10 mins):Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 2Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 3Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 4Health News:The Senior Citizens League (TSCL) Says Sixth Consecutive Year Of Record Low COLAs “Unprecedented” 2Health News:The Senior Citizens League (TSCL) Says Sixth Consecutive Year Of Record Low COLAs “Unprecedented” 3Health News:Immunotherapy could stop resistance to radiotherapy 2Health News:CDC Confirms First Patient Diagnosed With Ebola in United States 2Health News:CDC Confirms First Patient Diagnosed With Ebola in United States 3Health News:Researchers show EEG's potential to reveal depolarizations following TBI 2Health News:Researchers show EEG's potential to reveal depolarizations following TBI 3
... skateboarders have better self-esteem and lower tendencies to engage ... // ,The report of the study will ... authored by Melissa Nelson, professor and epidemiologist at the ... assistant professor of nutrition at the University of North ...
... being failed by the NHS says a joint report from ... Social Care Inspection. // Elder abuse is hurting old people, ... subject to patronising and thoughtless attitudes from some doctors and ... another, their meals are whisked away uneaten for lack of ...
... they had accomplished the transformation of immature cells from ... differentiate into nerve, heart and bone cells. // Their ... researchers in Valencia, Spain. Gerd Hasenfuss of Georg-August-University in ... that they have transformed mouse germ cells into stem ...
... of hundreds of birds in Peshawar and adjacent areas ... of blood samples to the National Veterinary Research Laboratory, ... that no case of bird flu was detected in ... had scared the people of the area following confirmation ...
... outbreak of measles occurred among the kids which were later ... the Central Middlesex Hospital in north-west London// began after two ... hundreds of hospital staffs are being vaccinated against measles. The ... the hospital scenario. ,Six nurses contracted the disease ...
... NHS of more than ?600,000 has been sentenced to three ... carried on// this fraud for more than six years during ... payment. ,The Hull Crown Court was told that ... work, which was never done. The dentist has earlier pleaded ...
Cached Medicine News:Health News:Neglect of the Elderly by the Community 2Health News:Bird Flu Not The Cause For Mysterious Bird Deaths 2
... Quieter Compressed Air., ,Allied Healthcares Timeter® PCS ... than other air compressors that you may wonder ... The PCS 414 features a durable, mar-resistant steel ... the unit weighs only 26.5 pounds. The PCS ...
... most compact, portable DC powered compressor ... provides the freedom to take nebulizer ... is powered by the included AC ... and Battery Kit. The integral reusable ...
The 45 PSI SuperSportNeb provides superior performance that translates to shorter treatment times. Like the SportNeb, it is constructed with die-cast aluminum compressor components for consistent rel...
... Compressor provides effective therapy at an affordable price. ... home or on the go and features ease ... reliable operation you have come to count on ... the perfect solution for those patients seeking a ...
Medicine Products: